[ad_1] Race Oncology Ltd (ASX:RAC) has launched a new corporate strategy focused on maximising bisantrene’s anti-cancer and cardio-protective potential. The company’s lead clinical focus will be on investigating anti-cancer, plus…
Tag: Oncology
RS Oncology presents new drug in early clinical development for Mesothelioma and lung cancer patients | BioSpace
[ad_1] Start-up US biotech company tackling rare diseases presents three case studies in France LILLE, France–(BUSINESS WIRE)– RS Oncology is bringing exciting new science to patients who will have the…
For second consecutive year, Roswell Park doesn’t make Top 50 in U.S. News cancer hospital rankings
[ad_1] For the second straight year, Roswell Park Comprehensive Cancer Center did not crack the Top 50 in the annual U.S. News & World Report ranking of the country’s top…
Amarillo business news: Texas Oncology center; Brown & Fortunato attorneys, more
[ad_1] Texas Oncology opens new, expanded comprehensive cancer center in Amarillo Texas Oncology has opened a new 50,000-square-foot cancer center in Amarillo, significantly expanding the capacity of the practice to…
Mark Cuban’s Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications
[ad_1] In a recent article published in the Journal of Clinical Oncology, researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug…
Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan
[ad_1] Data update from AFM24-101 phase 1/2 monotherapy study includes 15 patients from the EGFR mutant non-small cell lung cancer (NSCLC) cohort AFM24 showed clinical activity in 7 out of…
NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business
[ad_1] Tokyo (Japan), Hilversum (Netherlands), Oslo (Norway), Mannheim (Germany), March 31, 2023 – NEC Corporation (NEC) announced in 2019 that it would expand the application of its cutting-edge AI technologies…
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
[ad_1] FLORHAM PARK, N.J., March 30, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious…
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
[ad_1] Predictive Oncology Inc. EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository…